262 related articles for article (PubMed ID: 33425993)
1. Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis.
Cao M; Zhang J; Xu H; Lin Z; Chang H; Wang Y; Huang X; Chen X; Wang H; Song Y
Front Mol Biosci; 2020; 7():608368. PubMed ID: 33425993
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
[TBL] [Abstract][Full Text] [Related]
3. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
4. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
6. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
Liao Y; Liu Q; Xiao C; Zhou J
J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
[TBL] [Abstract][Full Text] [Related]
7. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
8. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
9. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
10. A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma.
Wei N; Chao-Yang G; Wen-Ming Z; Ze-Yuan L; Yong-Qiang S; Shun-Bai Z; Kai Z; Yan-Chao M; Hai-Hong Z
Front Pharmacol; 2022; 13():904448. PubMed ID: 36060009
[No Abstract] [Full Text] [Related]
11. Prognostic Signatures of Metabolic Genes and Metabolism-Related Long Non-coding RNAs Accurately Predict Overall Survival for Osteosarcoma Patients.
Chao-Yang G; Rong T; Yong-Qiang S; Tai-Cong L; Kai-Sheng Z; Wei N; Hai-Hong Z
Front Cell Dev Biol; 2021; 9():644220. PubMed ID: 33708772
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma.
Zhang JS; Pan RS; Tian XB
Front Oncol; 2023; 13():1156663. PubMed ID: 37035149
[TBL] [Abstract][Full Text] [Related]
13. A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.
Yang W; Wu H; Tong L; Wang Y; Guo Q; Xu L; Yan H; Yin C; Sun Z
Front Oncol; 2022; 12():1015094. PubMed ID: 36276092
[TBL] [Abstract][Full Text] [Related]
14. Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy.
Feng X; Zhao Z; Zhao Y; Song Z; Ma Y; Wang W
Front Mol Biosci; 2021; 8():783915. PubMed ID: 35127816
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
18. Development of a novel immune-related genes prognostic signature for osteosarcoma.
Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
[TBL] [Abstract][Full Text] [Related]
19. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]